SOURCE: StockCall

StockCall

September 29, 2010 09:03 ET

Equity Research on Vertex Pharmaceuticals and Warner Chilcott plc -- How Drug Companies Invest Their Money

JOHANNESBURG, SOUTH AFRICA--(Marketwire - September 29, 2010) -  www.stockcall.com/ offers investors comprehensive research on the drug manufacturers - other industry and has completed analytical research on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and Warner Chilcott plc (NASDAQ: WCRX). Register with us today at www.stockcall.com/ to have free access to these researches. 

Drug manufacturers have done well for themselves this year, with sales from existing products bringing in strong profits. However, the industry is continually faced with the problem of patient expiration. When drug patients expire, generally after five years, generic companies can start manufacturing generic alternatives, which take a huge chunk out of the original drug producer's profits. Some drug manufacturers actually pay generic companies not to make drugs. While this keeps down competition and secures prices, it can prove very costly. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the drug manufacturers - other industry.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the drug manufacturers - other industry can have easy and free access to our analyst research and opinions on Vertex Pharmaceuticals Incorporated and Warner Chilcott plc; investors and shareholders of these companies can simply register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

While preventing other companies from producing products can be expensive, it is not the only place drug manufacturers are spending their earnings. Drug manufacturers are also using their profits to purchase distribution rights. Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

Some companies the like of Warner Chilcott plc have been spending hundreds of millions of dollars to acquire U.S. distribution rights to top pharmaceutical products. Warner Chilcott plc research report is available for free by signing up now at www.stockcall.com/WCRX290910.pdf

Other companies have been heavily investing in research and development (R&D). New advancements in the treatment of hepatitis C have seen companies such as Vertex Pharmaceuticals Incorporated scrambling to produce safe and effective products. Vertex Pharmaceuticals Incorporated research report is accessible for free by registering today at www.stockcall.com/VRTX290910.pdf

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information